ARE THERE NEW OPTIONS TO TREAT ALCOHOL USE DISORDER? THE ANSWER MAY COME FROM RESEARCH BEING PRESENTED AT THE WONDERLAND CONFERENCE IN MIAMI. IT’S THE LARGEST PSYCHEDELIC MEDICINE CONFERENCE EVER. JOINING US IS ANTHONY TENNYSON, CEO AWAKN LIFE SCIENCES AND PROFESSOR DAVID NUTT FORMER CLINICAL DIRECTOR OF THE US NATIONAL INSTITUTE OF ALCOHOL ABUSE AND ALCOHOLISM WHO CURRENTLY WORKS AT AWAKN LIFE SCIENCES.
FOR MORE INFORMATION VISIT: AWAKNLIFESCIENCES.COM
This segment is provided to you by Awakn Life Sciences Corp
About Professor David Nuff
David is a former clinical director of the National Institute of Alcohol Abuse and Alcoholism in Washington, DC. David is a neuropsychopharmacologist and a world-renowned addiction expert. He is the Edmund J. Safra Professor of Neuropsychopharmacology in the Division of Brain Science at Imperial College London and the Chief Research Officer of Awakn Life Sciences. Here he uses a range of brain imaging techniques to explore the causes of addiction and other psychiatric disorders to search for new treatments.
About Anthony Tennyson
Anthony Tennyson is CEO at Awakn Life Sciences. Awakn is developing a better solution to treat addiction: psychedelic therapeutics – drugs and therapies used in combination. They are both a biotechnology company developing these proprietary therapeutics, and an operator of clinics where they deliver them.